Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $10.3950 (1.32%) ($10.3950 - $10.3950) on Wed. Mar. 2, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.43% (three month average) | RSI | 47 | Latest Price | $10.3950(1.32%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX advances 2% a day on average for past five trading days. | Weekly Trend | TGTX declines -2.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(77%) ARKG(72%) IBB(69%) ARKK(66%) IBUY(61%) | Factors Impacting TGTX price | TGTX will decline at least -3.715% in a week (0% probabilities). VIXM(-47%) VXX(-39%) UUP(-25%) TBT(-12%) EDOC(-5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.715% (StdDev 7.43%) | Hourly BBV | 0.6 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $1.58(-84.8%) | 5 Day Moving Average | $10.04(3.54%) | 10 Day Moving Average | $10.21(1.81%) | 20 Day Moving Average | $10.33(0.63%) | To recent high | -49.1% | To recent low | 22.7% | Market Cap | $1.317b | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |